The estimated score of CD8+ T cells, CD4+ central memory T cells (CD4+ Tcm), and Th1 cells were increased significantly in MTDH-low expression patients across diverse cancer types (Figures 4C–4E). This evidence concerns the gene CD4 and cancer.